|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/26/24 Shockwave Medical, Inc. 10-K 12/31/23 102:11M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.24M
2: EX-10.10 Material Contract HTML 104K
3: EX-10.16 Material Contract HTML 84K
4: EX-10.17 Material Contract HTML 40K
5: EX-21.1 Subsidiaries List HTML 30K
6: EX-23.1 Consent of Expert or Counsel HTML 28K
11: EX-97.1 Clawback Policy re: Recovery of Erroneously HTML 64K
Awarded Compensation
7: EX-31.1 Certification -- §302 - SOA'02 HTML 33K
8: EX-31.2 Certification -- §302 - SOA'02 HTML 33K
9: EX-32.1 Certification -- §906 - SOA'02 HTML 30K
10: EX-32.2 Certification -- §906 - SOA'02 HTML 30K
17: R1 Cover HTML 95K
18: R2 Audit Information HTML 34K
19: R3 Consolidated Balance Sheets HTML 145K
20: R4 Consolidated Balance Sheets (Parenthetical) HTML 49K
21: R5 Consolidated Statements of Operations and HTML 126K
Comprehensive Income (Loss)
22: R6 Consolidated Statements of Stockholders' Equity HTML 94K
23: R7 Consolidated Statements of Cash Flows HTML 150K
24: R8 Organization and Basis of Presentation HTML 33K
25: R9 Summary of Significant Accounting Policies HTML 110K
26: R10 Financial Instruments and Fair Value Measurements HTML 81K
27: R11 Cash Equivalents and Short-Term Investments HTML 81K
28: R12 Business Combinations HTML 67K
29: R13 Balance Sheet Components HTML 62K
30: R14 Goodwill and intangible assets HTML 57K
31: R15 Commitments and Contingencies HTML 58K
32: R16 Debt HTML 38K
33: R17 Convertible Debt HTML 39K
34: R18 Stock-Based Compensation HTML 86K
35: R19 Income Taxes HTML 120K
36: R20 Revenue HTML 55K
37: R21 Equity Method Investments HTML 35K
38: R22 Net Income (Loss) Per Share HTML 61K
39: R23 Pay vs Performance Disclosure HTML 40K
40: R24 Insider Trading Arrangements HTML 34K
41: R25 Summary of Significant Accounting Policies HTML 184K
(Policies)
42: R26 Summary of Significant Accounting Policies HTML 55K
(Tables)
43: R27 Financial Instruments and Fair Value Measurements HTML 77K
(Tables)
44: R28 Cash Equivalents and Short-Term Investments HTML 84K
(Tables)
45: R29 Business Combinations (Tables) HTML 67K
46: R30 Balance Sheet Components (Tables) HTML 65K
47: R31 Goodwill and intangible assets (Tables) HTML 62K
48: R32 Commitments and Contingencies (Tables) HTML 57K
49: R33 Stock-Based Compensation (Tables) HTML 82K
50: R34 Income Taxes (Tables) HTML 119K
51: R35 Revenue (Tables) HTML 50K
52: R36 Net Income (Loss) Per Share (Tables) HTML 61K
53: R37 Organization and Basis of Presentation (Details) HTML 31K
54: R38 Summary of Significant Accounting Policies - HTML 37K
Schedule of Reconciliation of Cash, Cash
Equivalents and Restricted Cash (Details)
55: R39 Summary of Significant Accounting Policies - HTML 49K
Additional Information (Details)
56: R40 Summary of Significant Accounting Policies - HTML 37K
Summary of Activity in Allowance for Doubtful
Accounts (Details)
57: R41 Summary of Significant Accounting Policies HTML 40K
(Details)
58: R42 Financial Instruments and Fair Value Measurements HTML 104K
- Schedule of Financial Assets and Liabilities
Measured at Fair Value (Details)
59: R43 Financial Instruments and Fair Value Measurements HTML 44K
- Additional Information (Details)
60: R44 Cash Equivalents and Short-Term Investments - HTML 70K
Summary of Cash Equivalents and Short-Term
Investments (Details)
61: R45 Cash Equivalents and Short-Term Investments - HTML 37K
Additional Information (Details)
62: R46 Cash Equivalents and Short-Term Investments - HTML 40K
Summary of Remaining Contractual Maturities for
Available-for-sale Securities (Details)
63: R47 Business Combination - Narrative (Details) HTML 60K
64: R48 Business Combination - Calculation of HTML 37K
Consideration Transferred (Details)
65: R49 Business Combination - Assets Acquired, HTML 77K
Liabilities Assumed (Details)
66: R50 Business Combination - Intangible Assets (Details) HTML 41K
67: R51 Business Combination - Pro Forma Information HTML 34K
(Details)
68: R52 Balance Sheet Components - Schedule of Inventory HTML 38K
(Details)
69: R53 Balance Sheet Components - Schedule of Property HTML 52K
and Equipment (Details)
70: R54 Balance Sheet Components - Additional Information HTML 31K
(Details)
71: R55 Balance Sheet Components - Schedule of Accrued HTML 45K
Liabilities (Details)
72: R56 Goodwill and intangible assets - Changes in HTML 37K
Carrying Amount of Goodwill (Details)
73: R57 Goodwill and intangible assets - Schedule of HTML 61K
Finite and Indefinite-Lived Intangible Assets
(Details)
74: R58 Goodwill and intangible assets - Narrative HTML 30K
(Details)
75: R59 Goodwill and intangible assets - Future HTML 44K
Amortization Expense (Details)
76: R60 Commitments and Contingencies - Additional HTML 45K
Information (Details)
77: R61 Commitments and Contingencies - Components of HTML 35K
Lease Costs (Details)
78: R62 Commitments and Contingencies - Schedule of HTML 52K
Minimum Future Rental Payments (Details)
79: R63 Commitments and Contingencies - Schedule of Future HTML 41K
Leases, Lease Payments (Details)
80: R64 Debt (Details) HTML 92K
81: R65 Convertible Debt (Details) HTML 97K
82: R66 Stock-Based Compensation - Schedule of Total HTML 41K
Stock-Based Compensation (Details)
83: R67 Stock-Based Compensation - Additional Information HTML 91K
(Details)
84: R68 Stock-Based Compensation - Schedule of Option HTML 75K
Activity under 2009 Plan and 2019 Plan (Details)
85: R69 Stock-Based Compensation - Schedule of RSU HTML 59K
Activity under 2019 Plan (Details)
86: R70 Stock-Based Compensation - Schedule of Fair Value HTML 57K
of ESPP Shares Estimated Using Black-Scholes
Option Pricing Model Assumptions (Details)
87: R71 Income Taxes -Schedule of Income (Loss) Before HTML 38K
Income Taxes (Details)
88: R72 Income Taxes - Schedule of Current Income Tax HTML 57K
Provision (Details)
89: R73 Income Taxes - Components of Deferred Tax Assets HTML 66K
and Liabilities (Details)
90: R74 Income Taxes - Reconciliation of Statutory Federal HTML 59K
Income Tax (Details)
91: R75 Income Taxes - Additional Information (Details) HTML 65K
92: R76 Income Taxes - Schedule of Unrecognized Tax HTML 38K
Benefits (Details)
93: R77 Revenue - Schedule of Product Revenue Based on HTML 44K
Product Line and Location (Details)
94: R78 Revenue - Schedule of Product Revenue Based on HTML 42K
Location (Details)
95: R79 Equity Method Investments (Details) HTML 56K
96: R80 Net Income (Loss) Per Share - Components of Basic HTML 71K
and Diluted Net Income (Loss) Per Share (Details)
97: R81 Net Income (Loss) Per Share - Summary of HTML 42K
Outstanding Potentially Dilutive Common Stock
Equivalents Excluded from Calculation of Diluted
Net Income (Loss) Per Share (Details)
99: XML IDEA XML File -- Filing Summary XML 180K
102: XML XBRL Instance -- swav-20231231_htm XML 2.15M
98: EXCEL IDEA Workbook of Financial Report Info XLSX 188K
13: EX-101.CAL XBRL Calculations -- swav-20231231_cal XML 316K
14: EX-101.DEF XBRL Definitions -- swav-20231231_def XML 662K
15: EX-101.LAB XBRL Labels -- swav-20231231_lab XML 2.27M
16: EX-101.PRE XBRL Presentations -- swav-20231231_pre XML 1.33M
12: EX-101.SCH XBRL Schema -- swav-20231231 XSD 189K
100: JSON XBRL Instance as JSON Data -- MetaLinks 628± 968K
101: ZIP XBRL Zipped Folder -- 0001642545-24-000063-xbrl Zip 986K
| Document |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/26/24 | None on these Dates | ||
| For Period end: | 12/31/23 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/06/24 Shockwave Medical, Inc. 10-Q 3/31/24 82:6.8M 4/29/24 Shockwave Medical, Inc. DEFM14A 1:2M Donnelley … Solutions/FA 4/26/24 Shockwave Medical, Inc. 10-K/A 12/31/23 15:995K Donnelley … Solutions/FA 4/18/24 Shockwave Medical, Inc. PREM14A 4/18/24 2:2M Donnelley … Solutions/FA 2/26/24 Shockwave Medical, Inc. S-8 2/26/24 4:124K |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/15/23 Shockwave Medical, Inc. 8-K:1,2,3,8 8/10/23 12:1.1M Donnelley … Solutions/FA 8/07/23 Shockwave Medical, Inc. 10-Q 6/30/23 81:7.2M 6/01/23 Shockwave Medical, Inc. 8-K:1,9 5/26/23 12:4.1M 2/27/23 Shockwave Medical, Inc. 10-K 12/31/22 86:10M 1/17/23 Shockwave Medical, Inc. 8-K:1,2 1/16/23 14:1.5M 10/20/22 Shockwave Medical, Inc. 8-K:1,2,9 10/19/22 2:1.5M 5/09/22 Shockwave Medical, Inc. 10-Q 3/31/22 70:5.5M Workiva Inc Wde… FA01/FA 9/29/21 Shockwave Medical, Inc. 8-K:1,9 9/27/21 12:946K Davis Polk & … LLP 01/FA 3/12/20 ShockWave Medical, Inc. 10-K 12/31/19 89:14M ActiveDisclosure/FA 3/12/19 ShockWave Medical, Inc. 8-K:3,5,9 3/11/19 5:282K Davis Polk & … LLP 01/FA 2/25/19 ShockWave Medical, Inc. S-1/A 10:4.7M Donnelley … Solutions/FA 2/08/19 ShockWave Medical, Inc. S-1 17:10M Donnelley … Solutions/FA |